Literature DB >> 22670022

The intersection of genes and environment: development of pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia and stimulant exposure.

Estela Ayala1, Kristina T Kudelko2, Francois Haddad3, Roham T Zamanian2, Vinicio de Jesus Perez4.   

Abstract

Pulmonary arterial hypertension (PAH) is a rare complication of hereditary hemorrhagic telangiectasia (HHT). The triggers that promote the development of PAH in HHT remain poorly understood. We present the case of a 45-year-old woman with decompensated right-sided heart failure secondary to newly diagnosed PAH. The clinical diagnosis of HHT was confirmed on the basis of recurrent spontaneous epistaxis, multiple typical mucocutaneous telangiectasia, and the presence of pulmonary arteriovenous malformation. There was also a suggestive family history. The patient was discovered to have active and extensive stimulant abuse in addition to HHT. We concluded that there may be a temporal relationship between exposure to stimulants and development of PAH in a host with underlying gene mutation. This case highlights the paradigm of PAH development after environmental exposure in a genetically susceptible host.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22670022      PMCID: PMC3367481          DOI: 10.1378/chest.11-1402

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

Review 1.  Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.

Authors:  S A Abdalla; M Letarte
Journal:  J Med Genet       Date:  2005-05-06       Impact factor: 6.318

2.  Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?

Authors:  Kelly M Chin; Richard N Channick; Lewis J Rubin
Journal:  Chest       Date:  2006-12       Impact factor: 9.410

3.  Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.

Authors:  Barbara Girerd; David Montani; Florence Coulet; Benjamin Sztrymf; Azzeddine Yaici; Xavier Jaïs; David Tregouet; Abilio Reis; Valérie Drouin-Garraud; Alain Fraisse; Olivier Sitbon; Dermot S O'Callaghan; Gérald Simonneau; Florent Soubrier; Marc Humbert
Journal:  Am J Respir Crit Care Med       Date:  2010-01-07       Impact factor: 21.405

Review 4.  Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).

Authors:  Vincent Cottin; Sophie Dupuis-Girod; Gaetan Lesca; Jean-François Cordier
Journal:  Respiration       Date:  2007       Impact factor: 3.580

  4 in total
  7 in total

Review 1.  Deregulation of Drosha in the pathogenesis of hereditary hemorrhagic telangiectasia.

Authors:  Akiko Hata; Giorgio Lagna
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

2.  Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.

Authors:  Roham T Zamanian; Haley Hedlin; Paul Greuenwald; David M Wilson; Joshua I Segal; Michelle Jorden; Kristina Kudelko; Juliana Liu; Andrew Hsi; Allyson Rupp; Andrew J Sweatt; Rubin Tuder; Gerald J Berry; Marlene Rabinovitch; Ramona L Doyle; Vinicio de Jesus Perez; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

Review 3.  Methamphetamine and the risk of pulmonary arterial hypertension.

Authors:  Ramon L Ramirez; Vinicio De Jesus Perez; Roham T Zamanian
Journal:  Curr Opin Pulm Med       Date:  2018-09       Impact factor: 3.155

4.  Pulmonary hypertension in a patient with hereditary haemorrhagic telangiectasia.

Authors:  Davinder Chadha; Ajay Handa; Abhishek Kumar
Journal:  BMJ Case Rep       Date:  2013-02-01

5.  Apolipoprotein E deficiency and high-fat diet cooperate to trigger lipidosis and inflammation in the lung via the toll-like receptor 4 pathway.

Authors:  Qiufang Ouyang; Ziyang Huang; Huili Lin; Jingqin Ni; Huixia Lu; Xiaoqing Chen; Zhenhua Wang; Ling Lin
Journal:  Mol Med Rep       Date:  2015-05-12       Impact factor: 2.952

6.  Sex-dependent right ventricular hypertrophic gene changes after methamphetamine treatment in mice.

Authors:  Hicham Labazi; Margaret Nilsen; Margaret R MacLean
Journal:  Eur J Pharmacol       Date:  2021-03-28       Impact factor: 4.432

7.  Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability.

Authors:  Sabine Revuz; Evelyne Decullier; Isabelle Ginon; Nicolas Lamblin; Pierre-Yves Hatron; Pierre Kaminsky; Marie-France Carette; Pascal Lacombe; Anne-Claire Simon; Sophie Rivière; Jean-Robert Harlé; Alain Fraisse; Christian Lavigne; Vanessa Leguy-Seguin; Ari Chaouat; Chahera Khouatra; Sophie Dupuis-Girod; Eric Hachulla
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.